De Novo Mutations in EIF2B1 Affecting eIF2 Signaling Cause Neonatal/Early-Onset Diabetes and Transient Hepatic Dysfunction
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Permanent neonatal diabetes mellitus (PNDM) is caused by reduced β-cell number or impaired β-cell function. Understanding of the genetic basis of this disorder highlights fundamental β-cell mechanisms. We performed trio genome sequencing for 44 patients with PNDM and their unaffected parents to identify causative de novo variants. Replication studies were performed in 188 patients diagnosed with diabetes before 2 years of age without a genetic diagnosis. EIF2B1 (encoding the eIF2B complex α subunit) was the only gene with novel de novo variants (all missense) in at least three patients. Replication studies identified two further patients with de novo EIF2B1 variants. In addition to having diabetes, four of five patients had hepatitis-like episodes in childhood. The EIF2B1 de novo mutations were found to map to the same protein surface. We propose that these variants render the eIF2B complex insensitive to eIF2 phosphorylation, which occurs under stress conditions and triggers expression of stress response genes. Failure of eIF2B to sense eIF2 phosphorylation likely leads to unregulated unfolded protein response and cell death. Our results establish de novo EIF2B1 mutations as a novel cause of permanent diabetes and liver dysfunction. These findings confirm the importance of cell stress regulation for β-cells and highlight EIF2B1’s fundamental role within this pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recent report details a de novo mutation in EIF2B1 affecting eIF2 signaling associated with permanent neonatal diabetes and hepatic dysfunction, similar to Wolcott-Rallison syndrome but with few severe comorbidities (161).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [161]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Genetic screening (i.e., next-generation sequencing) is increasingly available and cost-effective (161,163).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [161]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1×
“This knowledge is crucial to inform current efforts aimed at developing targeted therapies for patients with syndromic forms of diabetes caused by ER stress dysregulation (28,29) but also for patients with type 2 (30) and type 1 (31) diabetes, as ER stress is known to play a key role in the pathogenesis of these more…”
BackgroundThe integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659 · cited 6×
“The variants, four missense and one stop-loss, are all predicted to map to the same protein surface, and in silico modeling suggests that they are likely to disrupt the interaction of the EIF2Ba subunit (encoded by EIF2B1) with phosphorylated EIF2a during the cell ISR.”
BackgroundInfluentialHGVS Recommendations for the Description of Sequence Variants: 2016 Update
den Dunnen, J. T., Dalgleish, R., Maglott, D. R., Hart, R. K., Greenblatt, M. S., McGowan-Jordan, J., Roux, A.-F., Smith, T., Antonarakis, S. E., Taschner, P. E. M., et al. (2016) · Human Mutation · doi:10.1002/humu.22981 · Cited by 1,653
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., Mueckler, M., Marshall, H., Donis-Keller, H., Crock, P., et al. (1998) · Nature Genetics · doi:10.1038/2441 · Cited by 748
Zhang, P., McGrath, B., Li, S., Frank, A., Zambito, F., Reinert, J., Gannon, M., Ma, K., McNaughton, K., & Cavener, D. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3864-3874.2002 · Cited by 604
Insulin gene mutations as a cause of permanent neonatal diabetes
Støy, J., Edghill, E. L., Flanagan, S. E., Ye, H., Paz, V. P., Pluzhnikov, A., Below, J. E., Hayes, M. G., Cox, N. J., Lipkind, G. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707291104 · Cited by 564 · cited 1×
“These results further highlight the importance of ER stress regulation for β-cell function, adding another key gene to the list of ER stress regulators which, when mutated, cause syndromic forms of diabetes (4; 20-27).”
BackgroundSelf-citation井上, 寛. (2000) · Medical Entomology and Zoology · doi:10.11501/3171821 · Cited by 531 · cited 1×
“These results further highlight the importance of ER stress regulation for β-cell function, adding another key gene to the list of ER stress regulators which, when mutated, cause syndromic forms of diabetes (4; 20-27).”
Backgroundvan der Knaap, M. S., Leegwater, P. A. J., Könst, A. A. M., Visser, A., Naidu, S., Oudejans, C. B. M., Schutgens, R. B. H., & Pronk, J. C. (2002) · Annals of Neurology · doi:10.1002/ana.10112 · Cited by 381 · cited 1×
“Our patients’ clinical features are markedly different from those reported in patients with leukoencephalopathy with vanishing white matter (VWM), a rare pediatric neurological disease caused by recessive loss-of-function EIF2B1 mutations (13).”
ResultDe Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Self-citation
Research works printed but not linked: 1
- Konrad K F LC Grace T C BB Jessica A Qingbo W C RL L KM Andrea G B DP G LD Variation across 141,456 human exomes and genomes reveals the spectrum of loss-offunction intolerance across human protein-coding genes bioRxiv 2019
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“A recent report details a de novo mutation in EIF2B1 affecting eIF2 signaling associated with permanent neonatal diabetes and hepatic dysfunction, similar to Wolcott-Rallison syndrome but with few severe comorbidities (171).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
“Genetic screening is increasingly available and costeffective (138,140).”
Background2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus
Yong, J., Johnson, J. D., Arvan, P., Han, J., & Kaufman, R. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00510-4 · Cited by 228
Greeley, S. A. W., Polak, M., Njølstad, P. R., Barbetti, F., Williams, R., Castano, L., Raile, K., Chi, D. V., Habeb, A., Hattersley, A. T., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13426 · Cited by 211
Self-citationBonnefond, A., Unnikrishnan, R., Doria, A., Vaxillaire, M., Kulkarni, R., Mohan, V., Trischitta, V., & Froguel, P. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00421-w · Cited by 188
Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
Shrestha, N., De Franco, E., Arvan, P., & Cnop, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.650158 · Cited by 107
“Biallelic mutations in the EIF2AK3 gene (encoding PERK) and dominant mutations in EIF2B1 (resulting in loss of sensitivity of the EIF2B complex to eIF2a phosphorylation) result in syndromic forms of neonatal/early onset diabetes and likely bcell death (13, 14).”
BackgroundYIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress
De Franco, E., Lytrivi, M., Ibrahim, H., Montaser, H., Wakeling, M. N., Fantuzzi, F., Patel, K., Demarez, C., Cai, Y., Igoillo-Esteve, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141455 · Cited by 91
“Pathogenic variants in 8 genes known to be involved in regulating the ER stress response have been found to cause diabetes (ranging from neonatal to adolescent/adult-onset diabetes), often associated with neurological features (6, 16).”
BackgroundSelf-citationER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics
Ajoolabady, A., Wang, S., Kroemer, G., Klionsky, D. J., Uversky, V. N., Sowers, J. R., Aslkhodapasandhokmabad, H., Bi, Y., Ge, J., & Ren, J. T. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab006 · Cited by 86
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 89
“The second form, permanent neonatal diabetes, is most commonly caused by autosomal dominant mutation in the genes which encode the Kir.2 subunit (KCNJ11) and SUR1 subunit (ABCC8) of the β -cell K ATP channel and by mutation in gene EIF2B1 affecting eIF2 signaling [28].”
Normal and defective pathways in biogenesis and maintenance of the insulin storage pool
Liu, M. R., Huang, Y., Xu, X., Li, X., Alam, M., Arunagiri, A., Haataja, L., Ding, L., Wang, S., Itkin‐Ansari, P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142240 · Cited by 67
Dissection of type 2 diabetes: a genetic perspective
Bonnefond, A., Florez, J. C., Loos, R. J. F., & Froguel, P. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00339-5 · Cited by 54
Diabetes mellitus and the key role of endoplasmic reticulum stress in pancreatic β cells
Lytrivi, M., Tong, Y. A., Virgilio, E., Yi, X., & Cnop, M. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01129-5 · Cited by 45
“These mutations render eIF2B insensitive to eIF2α phosphorylation and presumably lead to uncontrolled β cell ER stress 180 .”
Sokolowski, E. K., Kursawe, R., Selvam, V., Bhuiyan, R. M., Thibodeau, A., Zhao, C. G., Spracklen, C. N., Ucar, D., & Stitzel, M. L. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.006 · Cited by 39
A (dis)integrated stress response: Genetic diseases of eIF2α regulators
English, A. M., Green, K. M., & Moon, S. L. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1689 · Cited by 36
Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
Moon, S., & Jung, H. S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0070 · Cited by 35
“Missense mutations in EIF2B1 also cause permanent neonatal diabetes mellitus, presumably due to a failure of eIF2B to sense eIF2 phosphorylation, leading to an unregulated UPR [30].”
BackgroundNeonatal diabetes mellitus around the world: Update 2024
Barbetti, F., Deeb, A., & Suzuki, S. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14312 · Cited by 31
Regulation and function of elF2B in neurological and metabolic disorders
Hanson, F. M., Hodgson, R. E., de Oliveira, M. I. R., Allen, K. E., & Campbell, S. G. (2022) · Bioscience Reports · doi:10.1042/bsr20211699 · Cited by 32
Genetic regulation of RNA splicing in human pancreatic islets
Atla, G., Bonàs‐Guarch, S., Cuenca-Ardura, M., Beucher, A., Crouch, D. J. M., García-Hurtado, J., Morán, I., Cnop, M., Eliasson, L., Esguerra, J. L. S., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02757-0 · Cited by 32
The role of eIF2 phosphorylation in cell and organismal physiology: new roles for well-known actors
Wang, X., & Proud, C. G. (2022) · Biochemical Journal · doi:10.1042/bcj20220068 · Cited by 29
The Role of ER Stress in Diabetes: Exploring Pathological Mechanisms Using Wolfram Syndrome
Morikawa, S., & Urano, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010230 · Cited by 23
Read, R. W., Schlauch, K. A., Lombardi, V. C., Cirulli, E. T., Washington, N. L., Lu, J. T., & Grzymski, J. J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.639418 · Cited by 19
Molecular mechanisms of β-cell dysfunction and death in monogenic forms of diabetes
Caballero, L. S., Gorgogietas, V. A., Arroyo, M. N., & Igoillo‐Esteve, M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.005 · Cited by 17
The application of precision medicine in monogenic diabetes
Barbetti, F., Rapini, N., Schiaffini, R., Bizzarri, C., & Cianfarani, S. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2035216 · Cited by 15
“In 2020, de novo missense (and a stop loss) variants of EIF2B1 were identified as cause of PNDM and liver dysfunction [71].”
BackgroundInfluentialNorris, K., Hodgson, R. E., Dornelles, T., Allen, K. E., Abell, B. M., Ashe, M., & Campbell, S. G. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014956 · Cited by 15
Iklé, J. M., & Gloyn, A. L. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0067 · Cited by 15
Hughes, A. E., Franco, E. D., Globa, E., Zelinska, N., Hilgard, D., Sifianou, P., Hattersley, A. T., & Flanagan, S. E. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13239 · Cited by 14
Self-citationRNA binding proteins PCBP1 and PCBP2 regulate pancreatic β cell translation
Haemmerle, M. W., Batmanov, K., Sen, S., Varney, M. J., Utecht, A. T., Good, A. L., Scota, A. V., Tersey, S. A., Ghanem, L. R., Philpott, C. C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102175 · Cited by 7
“…of translational controls in shaping b cell health is further highlighted by the observation that mutations in genes encoding key regulators of global rates of translation are associated with severe hyperglycemia, permanent diabetes, and substantial b cell loss in mice and humans [9 e 12].”
The Molecular Basis of Neonatal Diabetes Mellitus and Transient Hyperglycemia in the Neonate
Dermitzaki, N., Serbis, A., Baltogianni, M. S., Kosmeri, C., Balomenou, F., Tsiogka, C. M., & Giapros, V. I. (2026) · Applied Sciences · doi:10.3390/app16062649 · Cited by 2
Giannakopoulos, A., & Chrysis, D. (2024) · HORMONES · doi:10.1007/s42000-024-00552-z · Cited by 2
Vastrad, B. M., & Vastrad, C. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.15.608116 · Cited by 1
Current Perspectives in MODY Management—A Narrative Review
Deteșan, O., Custură, L. M., Kovács, B. I., Schmiedt, R. A., & Tilinca, M. C. (2021) · Timişoara Medical Journal · doi:10.35995/tmj20210204
Resnick, B., Shepherd, M. H., & Hattersley, A. T. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch20
Self-citationMédecine de précision du diabète de type 2 et des obésités génétiques
Collen, L. L. (2023) · theses.fr (ABES) · doi:10.70675/da43d89az5daez4be5z90f9z436fb96182a3
de Oliveira, M. I. R., Capper-Parkin, K., Campbell, S. G., & Allen, K. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.695478
Deeb, A., Barbetti, F., & Habeb, A. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00389-7
Ahmed, S., Lewis, V., Russ‐Silsby, J., Wakeling, M. N., Thunander, M., Vivanco, M., Caswell, R. C., Hattersley, A. T., Bowman, P., Patel, K., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106286
Self-citationLee, Y., Tong, M., & Gloyn, A. L. (2026) · FEBS Letters · doi:10.1002/1873-3468.70436
Metadata
- Authors
- De Franco, E., Caswell, R., Johnson, M. B., Wakeling, M. N., Zung, A., Dũng, V. C., Bích Ngọc, C. T., Goonetilleke, R., Vivanco Jury, M., El-Khateeb, M., Ellard, S., Flanagan, S. E., Ron, D., & Hattersley, A. T.
- Affiliations
- Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
- University of Exeter (GB)
- Hebrew University of Jerusalem (IL)
- Vietnam National Children's Hospital (VN)
- Vietnam National Children's Hospital, Hanoi, Vietnam
- Hinchingbrooke Hospital (GB)
- Hospital Roberto del Río, Universidad de Chile, Santiago, Chile
- National Center for Diabetes, Endocrinology and Genetic Diseases (JO)
- University of Cambridge (GB)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-03-01
- Volume
- 69
- Issue
- 3
- Pages
- 477-483
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7100014
- OpenAlex
- W2994666947
- Cited by
- 39
- References
- 32
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 2 · 2022: 8 · 2021: 12 · 2020: 4
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Diabetes UK (19/005971)
- European Foundation for the Study of Diabetes
- Diabetes Research & Wellness Foundation
- Wellcome Trust (WT098395/Z/12/Z, 105636/Z/14/Z, 200848/Z/16/Z)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- de novo mutations, permanent neonatal diabetes, early-onset diabetes, eIF2α phosphorylation, unfolded protein response, missense mutations
- MeSH terms
- Adolescent, Child, Preschool, Computer Simulation, Diabetes Mellitus, Female, Humans, Infant, Liver Diseases, Male, Models, Molecular, Mutation, Recurrence, Stress, Physiological, Eukaryotic Initiation Factor-2, Sequence Analysis, DNA, Mutation, Missense, Eukaryotic Initiation Factor-2B, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.